Alcohol Use Disorder (AUD) is a chronic relapsing brain disorder characterized by compulsive alcohol use, loss of control over alcohol intake, and a negative emotional state when not using. One of the most prevalent substance use disorders in the world — affecting an estimated 283 million people globally, with a burden disproportionately concentrated in high-income and upper-middle-income countries — AUD is associated with more than 200 disease and injury conditions, contributes to approximately 5.3% of all deaths worldwide, and imposes substantial economic costs through healthcare utilization, lost workplace productivity, and criminal justice involvement. AUD is a treatable chronic medical condition with multiple evidence-based interventions: Medications for Alcohol Use Disorder (MAUD) including naltrexone (oral and extended-release injectable), acamprosate, and disulfiram, combined with behavioral therapies including Motivational Enhancement Therapy (MET), Cognitive Behavioral Therapy (CBT) for substance use, Twelve-Step Facilitation, and SMART Recovery. The digital care technology ecosystem for AUD has expanded substantially, encompassing remote alcohol biomarker monitoring via transdermal ethanol sensor devices (SCRAM Continuous Alcohol Monitoring), FDA-cleared prescription digital therapeutics such as reSET-O for opioid use disorder with CBT modules applicable across substance use disorders, digital CBT for AUD platforms, medication adherence tracking applications, telehealth MAUD delivery platforms providing remote access to buprenorphine and naltrexone prescribing, and relapse risk early-warning systems integrating biometric, behavioral, and self-report signals.
When a transdermal ethanol monitoring platform loses contact with a patient's biosensor bracelet during a court-mandated monitoring period, the legal and clinical team has no confirmation of sobriety for the gap period — with potential consequences that include probation violations and treatment program dismissal. When a digital CBT for AUD platform goes offline during a patient's scheduled skill-building session, the behavioral intervention that sustains between-appointment relapse prevention skills is unavailable precisely when the patient has committed time and motivation. When a telehealth MAUD delivery platform fails on the day of a patient's monthly naltrexone injection appointment, the patient who cannot easily attend in person faces a gap in their pharmacotherapy that elevates relapse risk during the uncovered interval. For a condition defined by relapse vulnerability and managed through the consistent application of pharmacological and behavioral interventions, the continuous availability of digital care platforms is not infrastructure — it is treatment.
This guide explains what Alcohol Use Disorder care technology platforms must have monitored, why uptime directly determines treatment continuity and relapse prevention effectiveness, and how to build a monitoring configuration calibrated to the clinical and legal urgency of AUD care delivery.
Why AUD Care Tech Platforms Require Specialized Monitoring Attention
AUD care platforms coordinate across remote alcohol biomarker monitoring, digital CBT and behavioral skill building, medication adherence tracking, telehealth MAUD delivery, and relapse risk early-warning systems — each with distinct availability stakes and clinical urgency profiles that reflect both healthcare and legal accountability contexts.
Transdermal ethanol sensor monitoring platforms carry dual clinical and legal availability obligations. SCRAM (Secure Continuous Remote Alcohol Monitor) and similar transdermal ethanol monitoring devices worn as ankle bracelets collect continuous alcohol biomarker data and transmit readings to case management platforms used by courts, probation officers, drug court administrators, and clinical teams. A failure in the data ingestion pipeline or monitoring dashboard that creates an undetected gap in the sensor record can be interpreted as a tamper attempt or device malfunction, triggering legal proceedings for the patient. Monitoring platform availability must meet a standard beyond typical clinical SLAs; continuous monitoring pipelines that manage court-ordered devices are operationally equivalent to safety-critical systems. Monitor device telemetry ingestion, biomarker computation, tamper detection pipeline, case manager dashboard, and alert dispatch at 1-minute intervals, 24/7, with immediate alerting on any failure.
Digital CBT for AUD platforms deliver the behavioral relapse prevention skills that sustain recovery between clinical contacts. Digital CBT platforms for AUD provide structured skill-building modules covering drink refusal skills, urge surfing, cognitive restructuring for craving-related cognitions, functional analysis of drinking triggers, and social support activation. Patients in early recovery typically complete one to two modules per week on a prescribed schedule; a platform outage during a scheduled session window disrupts the behavioral skill acquisition sequence that builds cumulative relapse protection. Monitor session delivery service, CBT module availability, urge surfing and skill practice tools, patient progress API, and therapist review dashboard at 2-minute intervals during evening hours (18:00–22:00 local time), when patients most frequently engage with behavioral therapy content.
Medication adherence tracking platforms monitor naltrexone, acamprosate, and disulfiram administration continuity. Oral naltrexone and acamprosate require daily administration; disulfiram is typically taken three to five times weekly. Platforms that track medication administration logs — capturing patient self-report, connected pill dispenser data, or caregiver-observed administration — provide the adherence record that prescribers use to distinguish treatment failure from adherence failure when evaluating pharmacotherapy response. A failure in the medication log submission API creates gaps in the adherence record that cannot be retrospectively reconstructed. Monitor medication log submission, dispensing device integration, adherence trend computation, and prescriber dashboard at 2-minute intervals, 24/7.
Telehealth MAUD delivery platforms are the primary pharmacotherapy access pathway for patients unable to attend in-person clinics. Telehealth MAUD delivery — naltrexone initiation and ongoing management, acamprosate prescribing, extended-release injectable naltrexone (Vivitrol) administration coordination — has expanded access to evidence-based AUD pharmacotherapy substantially since regulatory changes enabling telehealth controlled-substance prescribing. For patients in rural areas, patients with transportation barriers, and patients whose AUD severity makes attendance at in-person appointments unreliable, telehealth may be the only available pharmacotherapy pathway. Monitor telehealth session initiation, prescriber scheduling, video stream availability, prescription generation, and pharmacy integration at 1-minute intervals during scheduled appointment windows, with immediate alerting.
Relapse risk early-warning systems integrate biometric and behavioral signals to detect elevated relapse risk before an event occurs. Platforms integrating wearable biometric data (HRV, sleep quality, activity patterns), digital diary entries (mood, craving intensity, social context), medication adherence patterns, and self-reported stress levels to compute composite relapse risk scores provide clinicians with an early-warning signal that can trigger a proactive clinical outreach before a relapse occurs. A pipeline failure that stops ingesting biometric or self-report data silently degrades the risk score's validity, while a failure in the alert dispatch system means a detected high-risk period generates no clinical notification. Monitor biometric data ingestion, self-report entry API, risk score computation, and clinical alert dispatch at 3-minute intervals, 24/7.
Motivational Enhancement Therapy and peer support platform integration sustain recovery community engagement. Digital MET tools, SMART Recovery online meeting platforms, and 12-Step digital community resources provide the social and motivational infrastructure that supports sustained recovery. Monitor peer support platform availability, meeting access, and digital mutual aid resource delivery at 3-minute intervals during active community engagement hours.
What to Monitor on an AUD Care Tech Platform
Transdermal Ethanol Sensor Monitoring and Tamper Detection
Monitor device telemetry ingestion pipeline, biomarker computation service, tamper detection algorithm, case manager dashboard, alert dispatch for compliance violations, and court/probation reporting API. Check at 1-minute intervals, 24/7. Alert immediately on any failure — SCRAM and similar monitoring platform outages have immediate legal consequences for patients.
Digital CBT Session Delivery and Behavioral Skill Practice
Monitor session delivery service, CBT module availability, urge surfing and skill practice tools, behavioral homework completion API, and therapist review dashboard. Check at 2-minute intervals during evening hours (18:00–22:00 local time). Alert after 5 minutes of sustained failure during active engagement windows.
Medication Adherence Tracking and Dispensing Integration
Monitor medication log submission API, connected dispenser integration endpoints, adherence trend computation, and prescriber adherence dashboard. Check at 2-minute intervals, 24/7. Alert after 5 minutes of sustained failure.
Telehealth MAUD Delivery and Prescriber Infrastructure
Monitor telehealth session initiation, prescriber scheduling portal, video stream availability, prescription generation service, and pharmacy integration API. Check at 1-minute intervals during scheduled appointment windows. Alert immediately on session initiation failures.
Relapse Risk Monitoring and Clinical Alert System
Monitor biometric data ingestion pipeline, self-report diary entry API, risk score computation service, and clinical alert dispatch for high-risk period detection. Check at 3-minute intervals, 24/7. Alert after 10 minutes of sustained biometric ingestion failure — silent pipeline failures degrade risk model validity without clinical awareness.
Peer Support and Recovery Community Platform
Monitor mutual aid platform availability, meeting access service, and digital recovery resource delivery. Check at 3-minute intervals during active community hours. Alert after 15 minutes of sustained failure.
EHR Integration and SUD Treatment Record Exchange
Monitor FHIR/HL7 integration endpoints exchanging AUD diagnoses, MAUD prescription records, CBT progress summaries, and relapse risk scores with the primary EHR. Alert after 10 minutes of sustained integration failure.
Authentication Across All Platform Roles
Monitor authentication for prescribers, therapists, case managers, court liaisons, and patients across all platform interfaces. Check at 1-minute intervals, 24/7. Authentication failures lock case managers and court liaisons out of compliance monitoring dashboards simultaneously with locking patients out of recovery support tools.
SSL Certificates Across All Domains
Monitor SSL certificate expiry across the SCRAM monitoring portal, CBT platform, medication adherence app, telehealth portal, and EHR integration domains. Configure 30-day advance warning alerts.
HIPAA and AUD Data Privacy Considerations
AUD care platforms handle substance use disorder diagnoses, controlled-substance prescription records, alcohol biomarker monitoring data, court-ordered monitoring records, relapse event documentation, and behavioral therapy progress notes — some of the most sensitive categories of protected health information, governed not only by HIPAA but by 42 CFR Part 2, the federal regulation that applies specifically to substance use disorder treatment records.
42 CFR Part 2 imposes stricter consent and disclosure requirements than standard HIPAA for SUD records: disclosing a patient's SUD treatment status — including to other treating providers — requires patient consent beyond what HIPAA permits without authorization. Platforms handling AUD treatment records must implement Part 2-compliant consent workflows, data segmentation that can prevent inadvertent SUD record disclosure in general EHR queries, and audit logging that demonstrates consent was obtained for every disclosure.
Court-ordered monitoring data — SCRAM records, compliance reports generated for probation or drug court — flows to non-healthcare entities and requires explicit consent frameworks covering law enforcement and judicial use of otherwise HIPAA-protected health data. Platforms handling dual clinical-legal data flows must implement clear data use agreements with court and probation stakeholders.
AUD and SUD diagnoses carry employment, insurance, and social consequences that create powerful incentives for disclosure minimization. Minimum necessary access controls, role-based data segmentation between clinical and legal stakeholders, and patient-accessible audit logs are essential components of platform data governance.
Uptime monitoring records documenting endpoint availability, SSL certificate validity, and response latency provide technical safeguard evidence for both HIPAA and 42 CFR Part 2 compliance audits.
Alerting Strategy for AUD Care Tech Platforms
Immediate 24/7 alert: Authentication across all platform roles; transdermal ethanol sensor telemetry ingestion and tamper detection pipeline. Transdermal monitoring failures have zero tolerance — gaps in court-ordered monitoring records carry immediate legal consequences.
Immediate business-hours alert: Telehealth session initiation during scheduled appointment windows; prescriber scheduling portal during clinic hours.
Sustained-failure alert (5 minutes): Digital CBT session delivery during evening engagement windows; medication adherence log submission, 24/7.
Sustained-failure alert (10 minutes): Relapse risk biometric ingestion pipeline; EHR integration endpoints.
Sustained-failure alert (15 minutes): Peer support and recovery community platform during active community hours.
30-day advance warning: SSL certificates across SCRAM monitoring portal, CBT platform, medication adherence app, telehealth portal, and EHR integration domains.
Vigilmon's multi-region monitoring verifies that AUD platform endpoints are reachable from the network regions where patients access behavioral therapy modules and medication adherence tools from home networks and mobile data, and where case managers and court liaisons access compliance monitoring dashboards from legal system networks — essential for detecting regional failures that could create compliance documentation gaps.
Status Page for Patient, Clinical, and Legal Stakeholder Communication
A real-time status page gives prescribers, therapists, case managers, court liaisons, and patients immediate confirmation when a suspected platform outage — a SCRAM monitoring dashboard that won't load, a CBT session that can't be initiated, a telehealth portal that times out on an appointment day — is confirmed as a known infrastructure incident rather than a local device issue.
The dual clinical-legal nature of AUD monitoring platforms means that status page communication must serve both healthcare and judicial stakeholders. Court liaisons and probation officers checking SCRAM compliance records need to be immediately informed of monitoring platform outages that may create compliance record gaps — so that judicial proceedings based on apparent non-compliance can be deferred pending resolution of the known platform incident. Status page visibility should therefore extend beyond clinical stakeholders to include court-designated monitoring supervisors.
For patients in early recovery, an unexplained platform failure — a CBT app that won't work, a medication tracking app that won't log — can itself be a stress trigger in the critical first weeks of treatment. A status page that confirms the outage quickly and provides a resolution timeline reduces the uncertainty burden on patients and allows them to maintain recovery behaviors while waiting for the platform to be restored.
Vigilmon Setup for AUD Care Tech Platforms
A practical starting configuration:
| Monitor | Check Interval | Alert Channel | |---------|----------------|---------------| | Authentication / all user roles | 1 min | PagerDuty (24/7, immediate) | | Transdermal ethanol telemetry and tamper detection | 1 min | PagerDuty (24/7, immediate) | | Digital CBT session delivery (evening window) | 2 min | Slack (sustained 5 min, 18:00–22:00) | | Medication adherence log submission | 2 min | Slack (sustained 5 min, 24/7) | | Telehealth MAUD session initiation | 1 min | Slack + PagerDuty (appointment windows) | | Relapse risk biometric ingestion | 3 min | Slack (sustained 10 min, 24/7) | | Peer support / recovery community platform | 3 min | Slack (sustained 15 min, community hours) | | EHR integration / FHIR endpoints | 5 min | Slack (sustained 10 min) | | SSL: all clinical and monitoring domains | Daily | Email (30-day warning) |
Getting started:
- Create a free account at vigilmon.online
- Add transdermal ethanol monitoring telemetry and tamper detection with 1-minute intervals and immediate PagerDuty alerting — this is the highest-stakes monitor on the platform
- Add authentication monitors across all roles with 1-minute intervals and immediate 24/7 alerting
- Configure telehealth MAUD session monitors with immediate alerting during appointment windows
- Add digital CBT session delivery with 5-minute sustained-failure alerting during evening hours
- Configure medication adherence log submission with 5-minute alerting, 24/7
- Add relapse risk biometric ingestion with 10-minute sustained-failure alerting
- Add peer support platform and EHR integration monitors
- Enable SSL certificate monitoring across all clinical, monitoring portal, and legal stakeholder-facing domains
- Publish the status page URL in patient, case manager, and court liaison onboarding materials
Conclusion
Alcohol Use Disorder care technology platforms coordinate across transdermal ethanol biomarker monitoring with court-ordered compliance obligations, digital CBT for relapse prevention skill-building, medication adherence tracking for daily naltrexone and acamprosate regimens, telehealth MAUD delivery for populations with barriers to in-person pharmacotherapy access, and relapse risk early-warning systems integrating biometric and behavioral signals. The dual clinical-legal nature of AUD monitoring creates availability standards more demanding than most healthcare platforms: a transdermal monitoring outage is not simply a technical failure — it is a compliance documentation gap with immediate potential legal consequences for the patient.
Uptime monitoring gives AUD care tech teams the detection capability to identify failures within seconds, respond before relapse prevention tools fail during critical behavioral skill-building windows, demonstrate sobriety monitoring continuity to court and probation stakeholders, and provide the technical safeguard documentation required by both HIPAA and 42 CFR Part 2 compliance frameworks.
Start monitoring your AUD care tech platform for free at vigilmon.online — HTTP/HTTPS monitoring, multi-region consensus alerting, SSL certificate monitoring, automatic status page, Slack and webhook alerts. No agent required. No credit card.
Tags: #monitoring #aud #alcoholusedisorder #maud #naltrexone #acamprosate #disulfiram #scram #transdermalmonitoring #digitalcbt #telehealth #substanceuserecovery #42cfr2 #hipaa #digitalhealth #uptime #sre